NODE. Health Meeting Report and Panel Discussion - The FDA's Changing Regulatory Landscape for Digital Health Technologies and Digital Health Innovation during COVID-19: A Discussion with Eric Topol and Bakul Patel, Moderated by Aenor Sawyer

Digit Biomark. 2020 Dec 3;4(3):128-133. doi: 10.1159/000512681. eCollection 2020 Sep-Dec.

¹ NODE. Health, New York, New York, USA.
² Penn State Clinical and Translational Science Institute, University Park, Pennsylvania, USA.
³ Division of Hospital Medicine, University of California, San Francisco, California, USA.
⁴ Translational Research Institute for Space Health, San Francisco, California, USA.

No abstract available

Keywords: COVID-19; Digital biomarkers; Evidence; Regulatory landscape; Wearables.